期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

快速筛选高水平稳定表达成纤维细胞生长因子-21真核细胞株新方法的建立 被引量：1

Establishment of a Novel Method for Rapid Screening of Eukaryotic Cell Lines Stably Expressing High Level FGF-21
原文传递
导出
摘要 成纤维细胞生长因子-21(FGF-21)是成纤维细胞生长因子家族的一名新成员,其研究已成为世界糖尿病研究的新热点,并有望成为治疗2型糖尿病的新型药物.然而,应用真核表达系统,更加快速、高效生产更接近天然状态的FGF-21蛋白并对其生物学功能进行的研究,至今尚未报道,因此建立高效稳定的FGF-21真核表达系统至关重要.本研究以FGF-21为目的基因,利用谷氨酰胺合成酶基因(GS)和绿色荧光蛋白基因(EGFP)作为筛选标记,分别构建了单基因表达载体Pee12.4-FGF-21-Pee6.4-EGFP(Peedual)、Pee12.4-FGF-21-IRES-EGFP(PeeIRES)和双基因的真核表达载体Pee12.4-FGF-21-IRES-EGFP-Pee6.4-FGF-21(Peedual-IRES),分别转染CHO-K1SV细胞后,通过GS加压和流式细胞术(在488 nm波长的激发光下能检测到EGFP绿色荧光)双筛选系统快速有效获得了稳定高效表达目的蛋白的细胞系.应用SDS-PAGE、Western印迹和ELISA检测细胞系目的蛋白的表达及差异,并通过HepG-2细胞糖吸收模型进行蛋白活性检测.研究结果表明:两个筛选系统结合使用,更好更快地筛选到了稳定转染并高效表达目的蛋白的细胞系,而且与单基因的载体相比,双基因载体Peedual-IRES在操作条件一致的情况下,目的蛋白表达量显著提高且均具有生物活性.本研究建立了省时、高效的真核表达平台,为FGF-21在真核水平上的高表达提供了一个新的方法. Fibroblast growth factor-21（FGF-21） is a new member of the fibroblast growth factor family,which has the potential to become a potential therapeutic agent for type 2 diabetes.To establish an efficient and stable recombinant eukaryotic expression system,together with a high-throughput screening method for the study of the biological function of FGF-21 are very important and practical.We cloned FGF-21 into Peedual IRES eukaryotic expression vectors alone and with GS or EGFP as the selectable markers.The CHO-K1SV cells transfected with these vectors were able to express FGF-21 at high levels,and could be isolated by GS selection and flow cytometry efficiently.Western blotting and ELISA were used to analyze the expression of the target protein from the transfected cells.The activity of FGF-21 on glucose metabolism regulation was tested with HepG2 cells.The glucose uptake levels were measured using the mini-glucose oxidase-preoxydase（GOD-POD） method.The results showed that FGF-21 stable transfected cell lines were obtained with the GS plus EGFP dual system,and the expression with the double-gene-vector（PeedualIRES）was better than those with Peedual and PeeIRES backbones.In this study,we have established an eukaryotic expression system that can be used for the rapid screening of eukaryotic cell lines expressing a FGF-21 gene as the target proteinidentification and screening.
作者 张雅坤 王文飞 何昆 叶贤龙 刘淼 韩苗苗 刘铭瑶 李德山
机构地区 东北农业大学生命科学学院生物制药教研室
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2012年第8期768-774,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 东北农业大学博士启动基金(No.2010RCB52)~~
关键词 真核表达 GS筛选系统 流式细胞术 FGF-21 eukaryotic expression GS selection flow cytometry fibroblast growth factor-21
分类号 Q786 [生物学—分子生物学]
  • 相关文献

参考文献15

  • 1Nishimccra T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expression in the liver[ J ]. Biochim Biophys Acta, 2000, 1492( 1 ) :203-206.
  • 2~haritonenkov A, Shiyanova T L, Koester A, et al. FGF-21 as a novel metabolic regulator [ J ]. J Clin Invest, 2005, 115 (6) : 1627-1635.
  • 3Coskun T, Bina H A, Schneider M A, et al. Fibroblast growth factor 21 corrects obesity in mice[J]. Endocrinology, 2008, 149 (12) :6018-6027.
  • 4Skehel J J, stevens D J, Daniels R S, et al. A carbonhydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody [ J ]. Proe Natl Acad Sei USA, 1984, 81(6) :1779-1783.
  • 5Cumming D A. Glycosidation of recombinant protein therapeutics: control and functional implications [ J ]. Glycobiology, 1991, 1(2) :115-130.
  • 6Conradt H S, Nitmz M, Dittmar K E, et al. Expression of human interleukin-2 in recombinant baby hamster kidney, Ltk-, and Chinese ovary ceils, tructure of O-linked carbohydrate chains and their location within the polypeptide [J]. J Biol Chem, 1989, 264 (29) : 17368-17373.
  • 7申烨华,耿信笃.CHO细胞表达系统研究新进展[J].生物工程进展,2000,20(4):23-25. 被引量：41
  • 8杨桂枝,高小平,晏菊芳,欧可群.GOD-POD法微量化测定方法的建立及其在3T3-L1脂肪细胞和HepG2细胞糖摄取中的应用[J].四川解剖学杂志,2003,11(1):12-15. 被引量：45
  • 9李晋南,刘铭瑶,侯玉婷,任桂萍,高华山,张振宇,李德山.人源FGF-21在脂肪细胞糖代谢中的作用[J].中国生物化学与分子生物学报,2009,25(6):556-562. 被引量：6
  • 10de la Cruz Edmonds M C,Tellers M, Chan C,et al. Development of transfection and high-producer screening protocols for the CHOK1SV cell system[J]. Mol Biotechnol, 2006, 34(2) :179- 190.

二级参考文献49

  • 1Wild S, Roglie G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 [ J ]. Diabetes Care, 2004, 27(5):1047-1053.
  • 2Sparano N, Seaton T L. Troglitazone in type Ⅱ diabetes menitus[ J ]. Pharmacotherapy, 1998,18(3) : 539-548.
  • 3Inzuechi S E, Maggs D G,Spollett GR, et al. Efficacy and metabolic effects of metformin and troglitazone in type Ⅱ diabetes mellitus [ J]. N Engl J Med, 1998,338(13) :867-872.
  • 4Mooradian AD. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly [J]. Drugs, 1996,51:931-941.
  • 5Scheen A J. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s: Achievements and future developments [J]. Drugs, 1997,54(3) :355-368.
  • 6Kharhonenkov A, Wroblewski V J, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 [J]. Endocrinology, 2007, 148(2): 774-781.
  • 7Kharitonenkov A, Shiyanova T L, Koester A, et al. FGF-21 as a novel metabolic regulator [J]. J Clin Invest, 2005, 115(6): 1627- 1635.
  • 8Wente W, Efanov A M, Brenner M, et al. FibrobIast growth factor- 21 improves pancreatic-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and akt signaling pathways [J]. Diabetes, 2006, 55(9): 2470-2478.
  • 9Marblestone J G, Edavettal S C, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO [ J ]. Protein Sci, 2006,15 ( 1 ) : 182-189.
  • 10Ausubel F M, Brent R, Kingston R E, et al. Short protocols in molecular biology, 3rd ed[ M ]. Boston : John Wiley, 1992,652-658.

共引文献104

同被引文献20

  • 1刘威,段海清,李淑琴,刘秀丽,张兆山.CHO细胞表达人源μ型阿片受体及其活性分析[J].中国生物化学与分子生物学报,2004,20(4):463-466. 被引量：1
  • 2王天云,薛乐勋,姬祥,王亚峰.核基质结合区提高报告基因在稳定转化的杜氏盐藻中的表达[J].中国生物化学与分子生物学报,2007,23(8):692-695. 被引量：6
  • 3Lai T, Yang Y, Ng S K. Advances in Mammalian cell line development technologies for recombinant protein production[ J]. Pharmaceuticals (Basel), 2013, 6(5) : 579-603.
  • 4Jayapal K P, Wlasehin K F, Hu W S, et al. Recombinant protein therapeutics from CHO cells -20 years and counting[ J]. Chem Eng Prog, 2007, 103(10) : 40-47.
  • 5Datta P, Linhardt R J, Sharfstein S T. An 'omics approach towards CHO cell engineering [ J ]. Biotechnol Bioeng, 2013, 110(5) : 1255-1271.
  • 6Chusainow J,Yang Y S, Yeo J H, et al. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? [ J]. Biotechnol Bioeng, 2009, 102 (4) : 1182-1196.
  • 7Wang F, Wang T Y,Tang Y Y, et al. Different matrix attachment regions flanking a transgene effectively enhance gene expression in stably transfected Chinese hamster ovary cells [ J ]. Gene, 2012, 500(1) : 59-62.
  • 8Zhang J H, Wang X Y, Wang T Y, et al. Distance effect of matrix attachment region on transgene expression in stably transfected Chinese hamster ovary ceils [ J ]. Biotechnol Lett, 2014, 3ti(10) : 1937-1943.
  • 9Wang T Y, Yang R, Qin C, et al. Enhanced expression of transgene in CHO cells using matrix attachment region[ J]. Cell Biol Int, 2008, 32(10) : 1279-1283.
  • 10Wang T Y, Zhang J H, Jing C Q, et al. Positional effects of the matrix attachment region on transgene expression in stably transfected CHO cells[J]. Cell Biol Int, 2010, 34(2): 141- 145.

引证文献1

中国生物化学与分子生物学报
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部